Regulation of ADP-ribosyltransferase activity by ART domain dimerization in PARP15

PARP15 is a mono-ADP-ribosyltransferase that targets an unknown set of proteins as well as RNA. Its evolutionary relationship with PARP14 suggests roles in antiviral defence; its localization to stress granules points to functions in the regulation of translation. Here we show that the transferase domain of PARP15 dimerizes in solution; the formation of dimers is a prerequisite for catalytic activity and monomeric mutant variants of the domain are inactive. In cells, dimer-disrupting mutations abrogate catalytic activity and alter the subcellular localization of the full-length protein. Using biophysical methods, including X-ray crystallography and HDX-MS, we provide evidence for a regulatory mechanism by which dimerization enables correct target engagement rather than NAD<sup>+</sup> co-substrate binding, and by which the two protomers of the dimer operate independently of one another. Together, our results uncover a regulatory mechanism in a PARP family enzyme.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2025-10-29
DOI
https://doi.org/10.1038/s41467-025-65315-9
Citations
1
Primary Topic
PARP inhibition in cancer therapy
Type
article
Field-Weighted Citation Impact
1.05

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Regulation of ADP-ribosyltransferase activity by ART domain dimerization in PARP15

Carmen Ebenwaldner, Antonio Ginés García Saura, Simon Ekström, Derek T. Logan et al.
1 citations
Nature Communications
PARP inhibition in cancer therapy
1.05
article

Regulation of ADP-ribosyltransferase activity by ART domain dimerization in PARP15

Carmen Ebenwaldner, Antonio Ginés García Saura, Simon Ekström, Derek T. Logan, M. Moche, Katja Bernfur, H. Schüler, Michael S. Cohen
article en
1 citations

Abstract

PARP15 is a mono-ADP-ribosyltransferase that targets an unknown set of proteins as well as RNA. Its evolutionary relationship with PARP14 suggests roles in antiviral defence; its localization to stress granules points to functions in the regulation of translation. Here we show that the transferase domain of PARP15 dimerizes in solution; the formation of dimers is a prerequisite for catalytic activity and monomeric mutant variants of the domain are inactive. In cells, dimer-disrupting mutations abrogate catalytic activity and alter the subcellular localization of the full-length protein. Using biophysical methods, including X-ray crystallography and HDX-MS, we provide evidence for a regulatory mechanism by which dimerization enables correct target engagement rather than NAD<sup>+</sup> co-substrate binding, and by which the two protomers of the dimer operate independently of one another. Together, our results uncover a regulatory mechanism in a PARP family enzyme.

Nature CommunicationsVol. 16(1)
Oregon Health & Science University (US), Lund University (SE), Karolinska Institutet (SE)
University of Lethbridge, Swedish Cancer Foundation, VINNOVA, Svenska Forskningsrådet Formas, Lunds Universitet, Karolinska Institutet, Vetenskapsrådet, Umeå Universitet, Science for Life Laboratory
Openalex Percentile: Top 16%
PARP inhibition in cancer therapy
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.